Close

Allergan (AGN), Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg to Treat Uterine Fibroids

January 17, 2017 6:58 AM EST Send to a Friend
Allergan Plc (NYSE: AGN) and Gedeon Richter Plc. today announced positive results from Venus II, the second of two pivotal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login